Trajectory of Lean Body Mass Assessed Using the Modified Creatinine Index and Mortality in Hemodialysis Patients.
Hemodialysis
body composition
body mass index (BMI)
creatinine index
end-stage renal disease (ESRD)
fat mass
lean body mass
mortality
muscle mass
nutritional status
obesity paradox
prognostication
protein-energy wasting (PEW)
survival
weight loss
weight trajectory
Journal
American journal of kidney diseases : the official journal of the National Kidney Foundation
ISSN: 1523-6838
Titre abrégé: Am J Kidney Dis
Pays: United States
ID NLM: 8110075
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
18
12
2018
accepted:
23
05
2019
pubmed:
30
9
2019
medline:
24
4
2020
entrez:
30
9
2019
Statut:
ppublish
Résumé
Although a declining body mass index (BMI) is associated with higher mortality in patients on hemodialysis, BMI cannot distinguish lean body mass from fat mass. It remains unclear whether changes over time in lean body mass are associated with mortality. We examined the prognostic significance of changes in the modified creatinine index, a proxy for lean body mass. Retrospective cohort study. Outpatients (n=349; mean age, 67.4 years; 60% men) undergoing maintenance hemodialysis 3 times a week at a treatment center. Modified creatinine index and BMI trajectories over a 1-year period. All-cause mortality. We calculated the percentage of change in modified creatinine index and BMI over a 1-year period. Patients were categorized according to change in modified creatinine index/BMI: no decline (≥0%) or decline (<0%). Kaplan-Meier and Cox proportional hazard analyses were performed to examine whether modified creatinine index and BMI trajectories were associated with mortality. During follow-up (median, 1,157 days), 79 patients died. Decreasing modified creatinine index (HR, 1.31; 95% CI, 1.11-1.54) and BMI (HR, 1.25; 95% CI, 1.01-1.54) over time, measured as continuous variables and expressed per 1-standard deviation decrease, were independently associated with higher risk for all-cause mortality. The decline in modified creatinine index/no decline in BMI group (HR, 2.14; 95% CI, 1.04-4.45) and the decline in modified creatinine index/decline in BMI group (HR, 3.05; 95% CI, 1.58-5.90) had higher rates of mortality compared to the no decline in modified creatinine index/decline in BMI group. The absence of a direct measure of lean body and fat mass and limited generalizability to non-Japanese hemodialysis populations. The modified creatinine index trajectory is independently associated with mortality and provides additional prognostic information to the BMI trajectory in patients on hemodialysis.
Identifiants
pubmed: 31563467
pii: S0272-6386(19)30859-5
doi: 10.1053/j.ajkd.2019.05.034
pii:
doi:
Substances chimiques
Biomarkers
0
Creatine
MU72812GK0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
195-203Informations de copyright
Copyright © 2019 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.